News
Quanticate reinforces global offering with new Indian office
Quanticate, a global data-focused clinical research organisation (CRO), is further expanding its service offering into India with the opening of a new office. ...
Industry Reports
ABL acquisition extends Ardena’s early-phase offering
Early-phase contract development and manufacturing organisation (CDMO), Ardena, has acquired bioanalytical contract laboratory, Analytical Biochemical Laboratory (ABL). The acquisition of Netherlands-based...
Clinical Trials
In Preclinical Trials Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection
Inovio Pharmaceuticals, Inc. announced that the development of its DNA-based monoclonal antibody program received a boost from two peer-reviewed scientific papers that demonstrate their...
News
CRF Health Augments Global Reach with Official Opening of Romania Office and Appointment of New VP Of Global Services
CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, will today officially open their Romania...
Clinical Trials
Datavant to Improve Clinical Trials with Artificial Intelligence launched by Roivant Sciences
Roivant Sciences, a global healthcare company focused on realizing the full value of promising biomedical research to improve the lives of patients and their...
Press Releases
Lonza Introduces the New CytoSMART™ 2 System for Live Cell Imaging
Lonza has introduced the CytoSMART™ 2 System, an updated version of Lonza’s popular CytoSMART™ System for live cell imaging. The CytoSMART™ 2 Device features...
News
Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention of Blood Vessel Occlusions Related to Vascular Interventions
Aplagon Oy (“Aplagon”) and Cadila Pharmaceuticals Sweden AB today announced a development and commercialization agreement for Aplagon’s lead APAC product. APACs are proprietary, locally...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read